Selective MT 2 melatonin receptor antagonists block melatonin‐mediated phase advances of circadian rhythms

Abstract
This study demonstrates the involvement of the MT2 (Mel1b) melatonin receptor in mediating phase advances of circadian activity rhythms by melatonin. In situ hybridization histochemistry with digox...
Funding Information
  • U.S. Public Health Service (MH 42922 and MH 52685, T32 ES 07124)